Autopsy report · NCT00643175
Effectiveness of Automated Inpatient Endocrinology Consultation for Osteoporotic Hip Fracture
Cause of deathStaffing, sites or logistics
“Dr. Grose has left this practice, this study is terminated”
Life of this trial
- Registered 9 months after it had already started.
- Ran for about 1 year 7 months before it stopped.
- 20 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- State University of New York - Upstate Medical University
- Sponsor type
- University, hospital or other
- Conditions
- Osteoporosis
- Interventions
- Automated follow up
- Participants
- 20 (planned, not actual)
- Sites
- 1
- Countries
- United States
Trials that died the same way
- A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration
“The study terminated for safety reasons” - A Study of Tadalafil for Duchenne Muscular Dystrophy
“The study is being terminated for lack of efficacy” - Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma
“Study was terminated due to high heterogeneity of enrolled patients” - The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"
“Study terminated due to lack of eligible patients” - Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer
“The study was terminated due to futility and lack of future funding”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.